Metabolomics

Researchers at TRI are studying molecular mechanisms that contribute to metabolic and cardiovascular homeostasis in the body, to develop improved diagnosis and treatment options for conditions including diabetes and cardiovascular disease.

Metabolic and cardiovascular processes often become defective in obesity, resulting in the development of chronic diseases such as type 2 diabetes and cardiovascular disease. In vitro and in vivo systems are used together with a range of techniques involving molecular and cellular biology combined with biochemistry and ‘omics’ approaches to define molecular mechanisms that contribute to cardiometabolic health.